Experimental study on the anti-malignant glioma effect of HSV-tk/GCV suicide gene therapy system enhanced by Cx43 gene

HUANG Qiang,PU Pei-yu,XIA Zhi-bo,JIANG Yuan-wen,YOU Yong-ping,ZHANG Yun-ting,WANG Chun-yan,WANG Guang-xiu,黄强,浦佩玉,夏之柏,蒋元文,尤永平,张云亭,王春燕,王广秀
DOI: https://doi.org/10.3760/CMA.J.ISSN.1671-8925.2007.09.006
2007-01-01
Abstract:Objective To study on the feasibility of enhancing the anti-tumor effect of suicide gene therapy using herpes simplex virus thymidine kinase/gancyclovir (HSV-tk/GCV) system for malignant gliomas by connexin43 (Cx43) gene.Methods C6 rat glioma cells cotransfected in vitro with lipofectamine-mediated Cx43 cDNA and adenovirus-mediated HSV-tk gene were exposed to ganciclovir (GCV) with different concentrations and MMT assay was applied to detect the survival rate of cells.Then the rat models were established by in vivo injection of C6 rat glioma cells into the tight caudate nucleus of Sprague-Dawley (SD) rats.Cx43 and HSV-tk genes were injected in situ and GCV was injected intraperitoneally;the survival time of all the tumor-bearing rats were observed;dynamic contrast-enhanced MRI was used to monitor the size of gliomas in tumor-bearing rats;in situ hybridization assay was used to detect the expressions of Cx43 and HSV-tk genes;and,TUNEL assay was used to detect apoptosis ofglioma cells.Results Cx43 evidently improved the anti-tumor effect of HSV-tk/GCV system on gliomas in vivo and in vitro by enhancing the bystander effect when about 50% of C6 glioma cells were transfected with tk gene.The concentration of GCV for ID_(50) and ID_(100) of C6 cells cotransfected with Cx43 cDNA and HSV-tk gene was 10 times lower than that transfected with HSV-tk gene alone.In vivo study:rats beating C6 gliomas treated by Cx43 gene transduction and HSV-tk/GCV system had evidently prolonged survival time (P<0.001) and higher apoptotic rate compared to those treated by HSV-tk/GCV alone.Contrast-enhanced MRI showed that intracranial tumors of three tumor-bearing rats disappeared within eight weeks.Conclusion Cx43 gene transduction significantly enhances the bystander effect of HSV-tk/GCV gene therapy.The combination of HSV-tk/GCV system with Cx43 gene transduction may be optimal for clinical therapeutic trials of gene therapy for malignant gliomas.
What problem does this paper attempt to address?